ArticleClinical neuropsychiatry2024
Reevaluating ADHD and its First-Line Treatment: Insights from DSM-5-TR and Modern Approaches.
Article in Clinical neuropsychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Society for Maternal-Fetal Medicine Statement: Acetaminophen use during pregnancy.Pregnancy (Hoboken, N.J.) · 2026Article
- Breaking down the ADHD construct to build a valid diagnosis.Acta neuropsychiatrica · 2026Review
- Four decades of ADHD: a systematic AI-assisted analysis of conceptual shifts across six DSM editions.Frontiers in psychiatry · 2026Article
- ADHD and Suicide Risk: The Overlooked Roles of Comorbid Disorders and Stimulant Medications.Clinical neuropsychiatry · 2025Article
- Health Side Story: Scoping Review of Literature on Narrative Therapy for ADHD.Healthcare (Basel, Switzerland) · 2025Review
- "Are You Sick? No, I am Neurodivergent!" The Perilous Navigation Between Medicalization and Diagnostic Nihilism.Clinical neuropsychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Is Attention Deficit Hyperactivity Disorder (ADHD) a "brain disorder"? Should it be managed regularly with stimulant drugs? This article critically examines the evolving biomedical discourse surrounding these questions through a close inspection of the latest edition of the influential psychiatric manual - the DSM-5-TR - as well as additional authoritative sources (e.g., previous DSM editions, consensus statements, FDA communications). The DSM-5-TR acknowledges that "
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.